Advanced Oncotherapy plc

Equities

AVO

GB00BD6SX109

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 07:30:00 30/06/2023 BST			5-day change	1st Jan Change
1.925 ^GBX	-.--%		+10.00%	+10.00%

05-09	Advanced Oncotherapy Delists from London Bourse Amid Financing Deal	MT
05-03	Advanced Oncotherapy financing talks continue, funds delayed	AN

Advanced Oncotherapy non-exec director buys 500,000 shares

December 30, 2022 at 02:34 pm

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Non-Executive Director Michael Bradfield buys 500,000 shares at 13.17 pence, worth GBP65,825, on Thursday. Now has 8.4 million shares, a 1.6% stake.

Current stock price: 13.84p, closed up 4.5% on Friday in London

12-month change: down 63%

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Latest news about Advanced Oncotherapy plc

Advanced Oncotherapy Delists from London Bourse Amid Financing Deal	05-09	MT
Advanced Oncotherapy financing talks continue, funds delayed	05-03	AN
Sareum ups retail offer; SThree nabs former ITV exec	04-02	AN
EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding	02-29	AN
Advanced Oncotherapy eyes USD15 million tranche in February	02-02	AN
Advanced Oncotherapy Faces Delay in Receiving $15 Million Funding from Investor	02-01	MT
Advanced Oncotherapy in advanced talks regarding loan	01-09	AN
Advanced Oncotherapy in talks over possible cash injection	23/10/23	AN
Advanced Oncotherapy Signs Deal with Investor for Potential $80 Million Funding	23/10/23	MT
Advanced Oncotherapy results delayed, funding talks continue	03/10/23	AN
Advanced Oncotherapy plans to raise up to GBP110 million	17/07/23	AN
FTSE 100 Closes Monday Down 0.4% Dragged by Miners	17/07/23	DJ
UK Finance Chiefs Are More Gloomy About Outlook	17/07/23	DJ
London Stocks Seen Opening Lower	17/07/23	DJ
Advanced Oncotherapy Announces Recapitalisation and Funding Plan	17/07/23	CI
Jadestone Energy holds production and capex targets	30/06/23	AN
FTSE 100 Closes Up 0.8% Lifted by Banks	30/06/23	DJ
Market Pricing of BOE's Interest-Rate Rises Seen Excessive	30/06/23	DJ
FTSE 100 Rises as UK Economy Avoids Contraction in 1Q	30/06/23	DJ
UK June House Price Slip Shows Buyer Pressures	30/06/23	DJ
Odey Asset Management Cuts Stake in De La Rue, Advanced Oncotherapy, Others	22/06/23	MT
Advanced Oncotherapy Receives Request for Partial Conversion of Notes to Shares	20/06/23	MT
Advanced Oncotherapy optimistic of securing further funding	02/06/23	AN
Advanced Oncotherapy plc announced that it has received £3.8626 million in funding	01/06/23	CI
Online Blockchain keeping ADVFN at "arms length"	15/05/23	AN

Chart Advanced Oncotherapy plc

Duration

Period

More charts

Company Profile

Advanced Oncotherapy Plc is a United Kingdom-based specialist developer and provider of a proton therapy system, the LIGHT system. The Companyâs team, ADAM, based in Geneva, is focused on the development of a proprietary proton accelerator called, Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control. The linear design of LIGHT allows for active longitudinal modulation along the proton beam axis and the variation of the proton beam by electronic means during cancer treatment. The modular feature of LIGHT offers hospitals and treatment centers the flexibility to customize cancer treatment plans based on a range of energies. Its subsidiaries include ADAM S.A., Advanced Oncotherapy Americas Inc, Advanced Oncotherapy B.V., Advanced Oncotherapy Resources Ltd, APTS Harley Street Ltd, Advanced Oncotherapy (China) Ltd, Advanced Oncotherapy Proton Therapy Services Ltd and other.

Sector

Advanced Medical Equipment & Technology

Calendar

25/06/2024 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ADVANCED ONCOTHERAPY PLC	+10.00%	12.03M
THERMO FISHER SCIENTIFIC	+12.50%	228B
DANAHER CORPORATION	+14.52%	196B
INTUITIVE SURGICAL, INC.	+17.51%	141B
BOSTON SCIENTIFIC CORPORATION	+28.96%	110B
SIEMENS HEALTHINEERS AG	+3.27%	65.88B
EDWARDS LIFESCIENCES CORPORATION	+18.16%	54.3B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.63%	52.39B
AGILENT TECHNOLOGIES, INC.	+10.95%	45.22B
GE HEALTHCARE TECHNOLOGIES INC.	+5.10%	37.12B

Other Advanced Medical Equipment & Technology